SLK-Kliniken Heilbronn GmbH Klinikum am Plattenwald
Bad Friedrichshall, Germany
Hospital in Baden-Württemberg
Am Plattenwald 1, 74177 Bad Friedrichshall
About SLK-Kliniken Heilbronn GmbH Klinikum am Plattenwald
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Abbott Medical Devices
2
Boehringer Ingelheim
2
Daiichi Sankyo, Inc.
2
German High-Grade Non-Hodgkin's Lymphoma Study Group
2
Universitätsklinikum Hamburg-Eppendorf
1
Clinical Trials at SLK-Kliniken Heilbronn GmbH Klinikum am Plattenwald
During the past decade, SLK-Kliniken Heilbronn GmbH Klinikum am Plattenwald conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
2001-01-01
2010-08-05
Completed
1,506
Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma
2004-02-01
2015-11-01
Completed
586
Septal Positioning of Ventricular Implanted Cardioverter Defibrillator (ICD) Leads
2008-08-01
2013-01-01
Completed
299
INvestigation on Routine Follow-up in CONgestive HearT FAilure Patients With Remotely Monitored Implanted Cardioverter Defibrillators (ICD) SysTems
2010-02-01
2014-07-01
Completed
210
Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)
2014-07-22
2017-06-05
Completed
2,725
Edoxaban Treatment in Routine Clinical Practice for Patients With Non Valvular Atrial Fibrillation
2015-08-01
2022-04-13
Completed
13,980
Intravenous Iron in Patients With Systolic Heart Failure and Iron Deficiency to Improve Morbidity & Mortality
2017-02-07
2024-05-01
Recruiting
1,200
EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)
2020-12-16
2023-08-31
Active, not recruiting
6,522
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "SLK-Kliniken Heilbronn GmbH Klinikum am Plattenwald" #1 sponsor was "Abbott Medical Devices" with 2 trials, followed by "Boehringer Ingelheim" with 2 trials
sponsored, "Daiichi Sankyo, Inc." with 2 trials sponsored, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 2 trials sponsored and "Universitätsklinikum Hamburg-Eppendorf"
with 2 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "SLK-Kliniken Heilbronn GmbH Klinikum am Plattenwald"
#1 collaborator was "Charite University, Berlin, Germany" with 1 trials as a collaborator, "Daiichi Sankyo Deutschland GmbH" with 1 trials as a collaborator, "Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at SLK-Kliniken Heilbronn GmbH Klinikum am Plattenwald
According to Clinical.Site data, the most researched conditions in "SLK-Kliniken Heilbronn GmbH Klinikum am Plattenwald" are
"Atrial Fibrillation" (2 trials), "Lymphoma" (2 trials), "Heart Failure" (1 trials), "Iron Deficiency" (1 trials) and "Myocardial Infarction" (1 trials). Many other conditions were trialed in "SLK-Kliniken Heilbronn GmbH Klinikum am Plattenwald" in a lesser frequency.
Clinical Trials Intervention Types at SLK-Kliniken Heilbronn GmbH Klinikum am Plattenwald
Most popular intervention types in "SLK-Kliniken Heilbronn GmbH Klinikum am Plattenwald" are "Drug" (7 trials), "Biological" (2 trials), "Other" (2 trials), "Radiation" (2 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Edoxaban" (2 trials), "cyclophosphamide" (2 trials), "doxorubicin hydrochloride" (2 trials), "prednisone" (2 trials) and "radiation therapy" (2 trials). Other intervention names were less common.
Clinical Trials Genders at SLK-Kliniken Heilbronn GmbH Klinikum am Plattenwald
The vast majority of trials in "SLK-Kliniken Heilbronn GmbH Klinikum am Plattenwald" are
9 trials for "All" genders.
Clinical Trials Status at SLK-Kliniken Heilbronn GmbH Klinikum am Plattenwald
Currently, there are NaN active trials in "SLK-Kliniken Heilbronn GmbH Klinikum am Plattenwald".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in SLK-Kliniken Heilbronn GmbH Klinikum am Plattenwald,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in SLK-Kliniken Heilbronn GmbH Klinikum am Plattenwald, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 2 trials that are defined as “Not Applicable".